TBC Bank Group Reports First Quarter 2025 Earnings
Revenue: GEL655.7m (up 14% from 1Q 2024).
Net income: GEL316.6m (up 8.1% from 1Q 2024).
Profit margin: 48% (down from 51% in 1Q 2024). The decrease in margin was driven by higher expenses.
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Looking ahead, revenue is forecast to grow 22% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Banks industry in the United Kingdom.
Performance of the British Banks industry.
The company's shares are down 6.7% from a week ago.
While earnings are important, another area to consider is the balance sheet. See our latest analysis on TBC Bank Group's balance sheet health.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
Morgan Stanley Raised The PT on Snowflake Inc. (SNOW), Maintains a Buy Rating
Snowflake Inc. (NYSE:SNOW) is one of the . On June 24, analyst Sanjit Singh from Morgan Stanley raised the price target on Snowflake Inc. (NYSE:SNOW) from $220 to $262, while maintaining a Buy rating on the stock. The improved outlook is based on the company's performance under CEO Sridhar Ramaswamy. Analyst Singh noted that Snowflake Inc. (NYSE:SNOW) has improved its execution across sales, go-to-market strategies, and product engineering, which has stabilized the company's product revenue growth to a high 20% range. Moreover, the has also enhanced its innovation across various high-growth sectors including cloud data warehousing, data engineering, and AI/ML platforms. A software engineer at work, surrounded by a wall of computer monitors connected to a 'Data Cloud' platform. Singh projects durable growth exceeding 20% annually through 2030, supported by expanding operating margins and a clear strategy to tap into a $300+ billion market opportunity. During the fiscal first quarter of 2026, Snowflake Inc. (NYSE:SNOW) grew its product revenue by 26% year-over-year to reach $996.8 million. The company also maintained a net revenue retention rate of 124%. Looking ahead, management anticipates second-quarter revenue between $1.035 billion to $1.040 billion, indicating 25% growth. While we acknowledge the potential of SNOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: The Best and Worst Dow Stocks for the Next 12 Months and 10 Unstoppable Stocks That Could Double Your Money. Disclosure: None.
Yahoo
an hour ago
- Yahoo
Should You Buy Palantir Stock After Its 2,100% Gain Since 2023? This Wall Street Analyst Has a Shocking Answer.
Palantir currently has a market value of $335 billion, but Wedbush Securities analyst Dan Ives says it could be a trillion-dollar company within three years. Palantir reported strong financial results in the first quarter, notching its seventh straight acceleration in sales growth due to strong demand for its AI platform. Palantir currently trades at 114 times sales, a valuation so rich that the shares price could fall 70% and it would still be the most expensive stock in the S&P 500. 10 stocks we like better than Palantir Technologies › Palantir Technologies (NASDAQ: PLTR) hit its stride when demand for artificial intelligence (AI) exploded after the launch of ChatGPT. The stock has soared 2,100% since January 2023, the best performance in the S&P 500 (SNPINDEX: ^GSPC) during that period by a wide margin. Today, most Wall Street analysts see the stock as overvalued. The median target price is $110 per share, which implies 23% downside from its current share price of $143. But Dan Ives at Wedbush Securities has consistently gone against the grain and been proved right time and time again: In September, Ives raised his target to $45 per share when the Wall Street consensus was $25. In November, Ives moved his target to $75 per share when the Wall Street consensus was $28. In January, Ives bumped his target to $90 per share when the Wall Street consensus was $41. Ives last month raised his target price to $140 per share. That implies a little downside in the near term, but he still sees Palantir as one of the best AI stocks investors can own despite the elevated valuation. In fact, he thinks Palantir will be a trillion-dollar company within three years. That forecast implies 199% upside from its current market value of $335 billion. Here's what investors should know. The International Data Corp. estimates artificial intelligence (AI) platform spending will increase at 40% annually through 2028. Palantir quickly became one of the largest players in that market following the launch of its AIP product in 2023. AIP adds support for large language models to the company's data operations platforms, Foundry and Gotham, which lets clients apply generative AI to their operations. Palantir says its key differentiator is an ontology-based software architecture. To elaborate, its products are built around a framework that links digital information to real-world assets. Users can parse that information with machine learning models and other analytical tools to uncover insights and optimize decision-making. And the feedback loop created by the software drives continuous improvements in the system. Morningstar analyst Mark Giarelli earlier this year wrote, "The core ontology function and value proposition is that Palantir not only organizes and displays data, but it also creates prioritized, ranked data that can be quickly understood and interacted with, ultimately automating real-world efficiency gains." Palantir reported impressive first-quarter financial results. Revenue increased 39% to $884 million, the seventh consecutive acceleration, driven by particularly strong sales growth in the U.S. commercial and government segments. Non-GAAP net income jumped 62% to $0.13 per diluted share. Management credited the strong results to demand for AIP and raised its full-year guidance, such that revenue is expected to increase 36% in 2025. Looking ahead, investors have good reason to think Palantir can maintain that momentum for the foreseeable future. Chief Technology Officer Shyam Sankar told analysts on the quarterly earnings call, "Our foundational investments in ontology and infrastructure have positioned us to uniquely deliver on AI demand now and in the years ahead." Palantir's business is firing on all cylinders, but the stock currently trades at 310 times adjusted earnings. That valuation is especially hard to justify because the Wall Street consensus says adjusted earnings will grow at 31% annually through 2026. Those numbers give a price-to-earnings-to-growth (PEG) ratio of 10. Multiples above 2 or 3 are usually considered overvalued. To further impress that point, consider this: Palantir currently trades at 114 times sales. The next closest stock in the S&P 500 is Texas Pacific Land, which currently trades at 33 times sales. The means Palantir could fall 70% and it would still be the most expensive stock in the S&P 500 as measured by its price-to-sales ratio. Here is the bottom line: I think Palantir could be a trillion-dollar company in the future, but I am skeptical about the three-year timeline Dan Ives proposed. The stock is outrageously expensive, so even the smallest speed bump could have a catastrophic impact on its share price. With so much downside risk, shareholders should keep their positions small, and prospective investors should wait for a much cheaper entry point. Before you buy stock in Palantir Technologies, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Palantir Technologies wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $687,731!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $945,846!* Now, it's worth noting Stock Advisor's total average return is 818% — a market-crushing outperformance compared to 175% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 23, 2025 Trevor Jennewine has positions in Palantir Technologies. The Motley Fool has positions in and recommends Palantir Technologies. The Motley Fool has a disclosure policy. Should You Buy Palantir Stock After Its 2,100% Gain Since 2023? This Wall Street Analyst Has a Shocking Answer. was originally published by The Motley Fool Sign in to access your portfolio
Yahoo
an hour ago
- Yahoo
GoodRx (GDRX) Unveils Lifecycle to Enhance Engineering Methodologies
GoodRx Holdings, Inc. (NASDAQ:GDRX) is one of the 10 best-value penny stocks to buy, according to analysts. On June 6, the company launched Lifecycle, a development tool designed to improve team velocity, streamline review workflows, and reduce infrastructure overhead. A healthcare professional discussing a treatment plan with a patient in an outpatient clinic. The tool enables engineering, quality control, and platform teams to automatically create temporary, isolated environments for testing and assessing code modifications under actual conditions. Lifecycle has also helped GoodRx minimize deployment challenges, enhance teamwork across different functions during code assessments, and decrease expenses related to prolonged staging infrastructure. The new tool underscores GoodRx's commitment to contemporary engineering methodologies and transparent collaboration. Lifecycle has been released to the public under the Apache 2.0 license, encouraging developers and organizations to adopt, enhance, and contribute to the platform's growth. 'Open sourcing Lifecycle reflects our commitment to transparency and to empowering developers. It's not just about sharing code, it's about sharing the ideas and practices that can help teams everywhere move faster and work smarter,' said Nitin Shingate, Chief Technology Officer at GoodRx. GoodRx Holdings, Inc. (NASDAQ:GDRX) is a digital healthcare platform that helps people find affordable prescription medications and other healthcare services. It primarily works by comparing drug prices at different pharmacies, offering discounts, and providing access to telemedicine services. While we acknowledge the potential of GDRX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
